Use of High‐Dose, Twice‐Yearly Albendazole and Ivermectin to SuppressWuchereria bancroftiMicrofilarial Levels-Reference-Cited by-同舟云学术

Use of High‐Dose, Twice‐Yearly Albendazole and Ivermectin to SuppressWuchereria bancroftiMicrofilarial Levels

Published:2010-12 Issue:11 Volume:51 Page:1229-1235
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Dembele Benoit,Coulibaly Yaya I.,Dolo Housseini,Konate Siaka,Coulibaly Siaka Y.,Sanogo Dramane,Soumaoro Lamine,Coulibaly Michel E.,Doumbia Salif Seriba,Diallo Abdallah A.,Traore Sekou F.,Diaman Keita Adama,Fay Michael P.,Nutman Thomas B.,Klion Amy D.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/51/11/1229/1058797/51-11-1229.pdf

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Applications of Ivermectin (IVM) in Dermatology;Chemistry and Biological Activities of Ivermectin;2023-09-12

2. Parasitological and epidemiological studies of Wuchereria bancrofti in Imobi, Ijebu East, Local Government Area of Ogun State, South Western Nigeria;The Journal of Basic and Applied Zoology;2021-10-14

3. Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire;Clinical Infectious Diseases;2021-03-01

4. Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial;Clinical Infectious Diseases;2021-01-19

5. Current use of ivermectin in dermatology, tropical medicine, and COVID-19: An update on pharmacology, uses, proven and varied proposed mechanistic action;Indian Dermatology Online Journal;2021